FlowCardia designs and develops catheter-based technologies for the treatment of totally occluded coronary and peripheral arteries.
FlowCardia, Inc. is a medical device company founded in 2002 to design and develop a portfolio of innovative, catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices is a major reason a large number of patients are still referred to coronary and peripheral bypass surgery and lower limb amputation.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 30, 2007 | Series C | $30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Rockport Venture Partners | — | Series C |